Boothbay Fund Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Boothbay Fund Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,100	Closed	-$485K	–	1213
2019 Q4	$485K	Buy	+8,100	New	+$304K	0.04%	495
2018 Q3	–	Sell	-10,755	Closed	-$411K	–	1014
2018 Q2	$411K	Buy	+10,755	New	+$398K	0.04%	390

Boothbay Fund Management's BOLD Position: Q1 2020 in Review

Boothbay Fund Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 8,100 shares — an estimated $485K sold.

Boothbay Fund Management first reported a position in BOLD in Q2 2018 and held it in 2 quarters. The position peaked at $485K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Boothbay Fund Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Boothbay Fund Management sold 8,100 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $485K.
Boothbay Fund Management first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 2 quarters.
Boothbay Fund Management's Audentes Therapeutics, Inc position peaked at $485K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.